ARB-1740, a RNA Interference Therapeutic for Chronic Hepatitis B Infection

2019/03/20

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/30403127

Thi, E. P. Dhillon, A. P. Ardzinski, A. Bidirici-Ertekin, L. Cobarrubias, K. D. Cuconati, A. Kondratowicz, A. S. Kwak, K. Li, A. H. L. Miller, A. Pasetka, C. Pei, L.Phelps, J. R. Snead, N. M. Wang, X. Ye, X. Sofia, M. J. Lee, A. C. H.

ACS Infect Dis. 2018 Nov 19. doi: 10.1021/acsinfecdis.8b00191.

VIEW AS PDF

Endoplasmic reticulum-mediated induction of interleukin-8 occurs by hepatitis B virus infection and contributes to suppression of interferon responsiveness in human hepatocytes

2018/11/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/30240958

Tsuge, M. Hiraga, N. Zhang, Y. Yamashita, M. Sato, O. Oka, N. Shiraishi, K. Izaki, Y. Makokha, G. N. Uchida, T. Kurihara, M. Nomura, M. Tsushima, K. Nakahara, T. Murakami, E. Abe-Chayama, H. Kawaoka, T. Miki, D. Imamura, M. Kawakami, Y. Aikata, H. Ochi, H. Hayes, C. N. Fujita, T. Chayama, K.

Virology. 2018 Sep 18;525:48-61. doi: 10.1016/j.virol.2018.08.020.

VIEW AS PDF

Chimeric mice with humanized livers demonstrate human-specific hepatotoxicity caused by a therapeutic antibody against TRAIL-receptor 2/death receptor 5

2018/11/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/30202993

Nihira, K. Nan-Ya, K. I. Kakuni, M. Ono, Y. Yoshikawa, Y. Ota, T. Hiura, M. Yoshinari, K.

Toxicol Sci. 2018 Sep 9. pii: 5093319. doi: 10.1093/toxsci/kfy228.

VIEW AS PDF

CTL-associated and NK cell-associated immune responses induce different HBV DNA reduction patterns in chronic hepatitis B patients

2018/11/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29998562

Nomura, M. Tsuge, M. Uchida, T. Hiraga, N. Kurihara, M. Tsushima, K. Fujino, H. Nakahara, T. Murakami, E. Abe-Chayama, H. Kawaoka, T. Miki, D. Hiramatsu, A. Imamura, M. Kawakami, Y. Aikata, H. Ochi, H. Zhang, Y. Makokha, G. N. Hayes, C. N. Tanaka, S. Chayama, K.

J Viral Hepat. 2018 Jul 11. doi: 10.1111/jvh.12970.

VIEW AS PDF

The metabolic fate of fenclozic acid in chimeric mice with a humanized liver

2018/11/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/30094548

Ekdahl, A. Weidolf, L. Baginski, M. Morikawa, Y. Thompson, R. A. Wilson, I. D.

Arch Toxicol. 2018 Sep;92(9):2819-2828.

VIEW AS PDF

Inhibitory effect of fasiglifam on hepatitis B virus infections through suppression of the sodium taurocholate cotransporting polypeptide

2018/11/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29723527

Nio, Y. Akahori, Y. Okamura, H. Watashi, K. Wakita, T. Hijikata, M.

Biochem Biophys Res Commun. 2018 Jun 27;501(3):820-825.

VIEW AS PDF

Inhibitory effect of silibinin on hepatitis B virus entry

2018/11/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29872730

Umetsu, T. Inoue, J. Kogure, T. Kakazu, E. Ninomiya, M. Iwata, T. Takai, S. Nakamura, T.Sano, A. Shimosegawa, T.

Biochem Biophys Rep. 2018 Mar 31;14:20-25.

VIEW AS PDF

A long-term culture system based on a collagen vitrigel membrane chamber that supports liver-specific functions of hepatocytes isolated from mice with humanized livers

2018/11/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/30078838

Watari, R. Kakiki, M. Oshikata, A. Takezawa, T. Yamasaki, C. Ishida, Y. Tateno, C. Kuroda, Y. Ishida, S. Kusano, K.

J Toxicol Sci. 2018;43(8):521-529.

VIEW AS PDF

Inhibitory effect of Japanese rice-koji miso extracts on hepatitis A virus replication in association with the elevation of glucose-regulated protein 78 expression

2018/11/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/30123052

Win, N. N. Kanda, T. Nakamoto, S. Moriyama, M. Jiang, X. Suganami, A. Tamura, Y. Okamoto, H. Shirasawa, H.

Int J Med Sci. 2018 Jul 30;15(11):1153-1159.

VIEW AS PDF

新規ready-to-use ヒト肝細胞三次元培養システム「PXB-able」の有用性の検討

2018/08/14

Pub Med URL http://mol.medicalonline.jp/archive/search?jo=ao8bioib&ye=2018&vo=35&issue=3

赤平有希、山崎ちひろ、石田雄二、立野知世、城村友子

BIO-INDUSTRY 2018;35（3）：27-37

VIEW AS PDF

Contribution of chimeric mice with a humanized liver to the evaluation of pharmacology, toxicity, and pharmacokinetics in drug discovery and development

2018/08/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29760366

Sanoh, S. Ohta, S.

Nihon Yakurigaku Zasshi. 2018;151(5):213-220

VIEW AS PDF

Use of hepatocytes isolated from a liver-humanized mouse for studies on the metabolism of drugs: application to the metabolism of fentanyl and acetylfentanyl

2018/08/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29963210

Kanamori, T. Togawa-Iwata, Y. Segawa, H. Yamamuro, T. Kuwayama, K. Tsujikawa, K. Inoue, H.

Forensic Toxicol. 2018;36(2):467-475.

VIEW AS PDF

Limitations of daclatasvir/asunaprevir plus beclabuvir treatment in cases of NS5A inhibitor treatment failure

2018/08/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29916799

Teraoka, Y. Uchida, T. Imamura, M. Hiraga, N. Osawa, M. Kan, H. Saito, Y. Tsuge, M. Abe-Chayama, H. Hayes, C. N. Makokha, G. N. Aikata, H. Miki, D. Ochi, H. Ishida, Y. Tateno, C. Chayama, K.

J Gen Virol. 2018 Jun 19. doi: 10.1099/jgv.0.001091.

VIEW AS PDF

Generation of the Adenovirus Vector-Mediated CRISPR/Cpf1 System and the Application for Primary Human Hepatocytes Prepared from Humanized Mice with Chimeric Liver

2018/08/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29962404

Tsukamoto, T. Sakai, E. Iizuka, S. Taracena-Gandara, M. Sakurai, F. Mizuguchi, H.

Biol Pharm Bull. 2018;41(7):1089-1095. doi: 10.1248/bpb.b18-00222.

VIEW AS PDF

The whole transcriptome effects of the PPARalpha agonist fenofibrate on livers of hepatocyte humanized mice

2018/08/14

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29879903

de la Rosa Rodriguez, M. A. Sugahara, G. Hooiveld, Gjej Ishida, Y. Tateno, C. Kersten, S.

BMC Genomics. 2018 Jun 7;19(1):443. doi: 10.1186/s12864-018-4834-3.

VIEW AS PDF

Chimeric mice with humanized liver: Application in drug metabolism and pharmacokinetics studies for drug discovery

2018/05/22

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29183653

Naritomi, Y. Sanoh, S. Ohta, S.

Drug Metab Pharmacokinet. 2017 Nov 9. pii: S1347-4367(17)30150-7. doi: 10.1016/j.dmpk.2017.11.001.

VIEW AS PDF

Identifying and Characterizing Interplay between Hepatitis B Virus X Protein and Smc5/6

2018/05/22

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/28368357

Livingston, C. M. Ramakrishnan, D. Strubin, M. Fletcher, S. P. Beran, R. K.

Viruses. 2017 Apr 3;9(4). pii: E69. doi: 10.3390/v9040069.

VIEW AS PDF

Propagation of Human Hepatocytes in uPA/SCID Mice: Producing Chimeric Mice with Humanized Liver

2018/05/22

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/27830547

Ohshita, H. Tateno, C.

Methods Mol Biol. 2017;1506:91-100. (Book of Hepatocyte Transplantation)

VIEW AS PDF

Prevalence of NS5A resistance associated variants in NS5A inhibitor treatment failures and an effective treatment for NS5A-P32 deleted hepatitis C virus in humanized mice

2018/05/22

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29621544

Teraoka, Y. Uchida, T. Imamura, M. Osawa, M. Tsuge, M. Abe-Chayama, H. Hayes, C. N. Makokha, G. N. Aikata, H. Miki, D. Ochi, H. Ishida, Y. Tateno, C. Chayama, K.

Biochem Biophys Res Commun. 2018 Jun 2;500(2):152-157.

VIEW AS PDF

Inhibitory effects of drugs on the metabolic activity of mouse and human aldehyde oxidases and influence on drug-drug interactions

2018/05/22

Pub Med URL https://www.ncbi.nlm.nih.gov/pubmed/29678521

Takaoka, N. Sanoh, S. Okuda, K. Kotake, Y. Sugahara, G. Yanagi, A. Ishida, Y. Tateno, C. Tayama, Y. Sugihara, K. Kitamura, S. Kurosaki, M. Terao, M. Garattini, E. Ohta, S.

Biochem Pharmacol. 2018 Apr 17;154:28-38.

VIEW AS PDF